Fisher & Paykel Healthcare Corporation Limited
Simbolis: FPH.AX
ASX
23.66
AUDRinkos kaina šiandien
61.8116
P/E santykis
3.7087
PEG koeficientas
13.82B
MRK kapitalizacija
- 0.01%
DIV pajamingumas
Fisher & Paykel Healthcare Corporation Limited (FPH-AX) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 113.3 | 268.5 | 347.2 | |||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0.5 | 185.3 | 257.7 | |||||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 237.9 | 169.2 | 210.5 | |||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 342.4 | 332.4 | 248.8 | |||||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 31.1 | 52.2 | 39.4 | |||||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 724.6 | 822.4 | 846 | |||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 1074.7 | 887.2 | 811.1 | |||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 80.1 | 80.4 | 73.6 | |||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 80.1 | 80.4 | 73.6 | |||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 93.5 | 84.2 | 102.6 | |||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 90.4 | 77.4 | 74.8 | |||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1338.7 | 1129.2 | 1062 | |||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 2063.4 | 1951.6 | 1908 | |||||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 40.2 | 49.8 | 52.1 | |||||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 19.9 | 15.7 | 24.5 | |||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 6.2 | 29.5 | 137.6 | |||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 74 | 58.4 | 57.7 | |||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 42.5 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 204.9 | 186.4 | 178.9 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 151 | 114.3 | 116.4 | |||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 42.5 | 22.5 | 26.7 | |||||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 422.2 | 395.8 | 509.5 | |||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 287.3 | 246.7 | 231.1 | |||||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 1123.6 | 1094.1 | 946.4 | |||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 233.2 | 219.8 | 223.1 | |||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -3.1 | -4.7 | -2 | |||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1641.1 | 1555.9 | 1398.5 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 2063.4 | 1951.6 | 1908 | |||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 1641.1 | 1555.9 | 1398.5 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||||||
Total Investments | 0 | 93.5 | 269.5 | 360.4 | |||||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 136.5 | 96.6 | 108.9 | |||||||||||||||||||||||
balance-sheet.row.net-debt | 0 | 23.2 | 13.3 | 19.4 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 234.3 | 349.1 | 482 | |||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 92.7 | 88.9 | 78.2 | |||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 4.5 | -6.3 | -54.3 | |||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -250.1 | -216.3 | -214.7 | |||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -64.8 | -38.4 | -58.4 | |||||||||||||||||||||||
cash-flows.row.account-receivables | 0 | -40.5 | 48.6 | -4.7 | |||||||||||||||||||||||
cash-flows.row.inventory | 0 | -6.5 | -81.8 | -114.1 | |||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -17.8 | -5.3 | 60.4 | |||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 206.4 | 123.4 | 342.2 | |||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -197.8 | -157.3 | -169.8 | |||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -186.3 | |||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 187.2 | 74.4 | 0 | |||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -10.6 | -82.9 | -356.1 | |||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -9.4 | -0.1 | -45.3 | |||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 2.8 | 3 | 3.2 | |||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0.9 | 1 | 46.1 | |||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -183.2 | -208.3 | -166.7 | |||||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 4.3 | -14 | -10.2 | |||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -184.5 | -218.4 | -172.9 | |||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 2.4 | 0.2 | -1 | |||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 30 | -6.2 | 24.5 | |||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 113.3 | 83.3 | 89.5 | |||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 83.3 | 89.5 | 65 | |||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 222.9 | 300.4 | 575 | |||||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -197.8 | -157.3 | -169.8 | |||||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 25.2 | 143.1 | 405.1 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1486.9 | 1521.3 | 1791.4 | |||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 601.6 | 582.6 | 667.2 | |||||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 885.3 | 938.7 | 1124.2 | |||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | -7.6 | 40.2 | 32.4 | |||||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 567.4 | 506.8 | 490.4 | |||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1168.9 | 1089.4 | 1157.6 | |||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 2.4 | 2.4 | 1.4 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 6.3 | 4.5 | 4.6 | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -11 | 35.1 | 26.6 | |||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -7.6 | 40.2 | 32.4 | |||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -11 | 35.1 | 26.6 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 6.3 | 4.5 | 4.6 | |||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 92.7 | 88.9 | 78.2 | |||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.operating-income | 0 | 318 | 431.9 | 633.8 | |||||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 307 | 467 | 660.4 | |||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 72.7 | 117.9 | 178.4 | |||||||||||||||||||||||
income-statement-row.row.net-income | 0 | 250.3 | 376.9 | 524.2 |
Dažnai užduodami klausimai
Kas yra Fisher & Paykel Healthcare Corporation Limited (FPH.AX) bendras turtas?
Fisher & Paykel Healthcare Corporation Limited (FPH.AX) bendras turtas yra 2063359237.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra N/A.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.601.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 0.051.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra 0.153.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra 0.219.
Kas yra Fisher & Paykel Healthcare Corporation Limited (FPH.AX) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 250300000.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 136465310.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 567388691.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 0.000.